Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Conmed (CNMD) Invested Capital (2016 - 2025)

Conmed's Invested Capital history spans 16 years, with the latest figure at $1.1 billion for Q4 2025.

  • For Q4 2025, Invested Capital rose 11.45% year-over-year to $1.1 billion; the TTM value through Dec 2025 reached $1.1 billion, up 11.45%, while the annual FY2025 figure was $1.1 billion, 11.45% up from the prior year.
  • Invested Capital reached $1.1 billion in Q4 2025 per CNMD's latest filing, roughly flat from $1.1 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $1.1 billion in Q1 2025 to a low of $673.0 million in Q2 2022.
  • Average Invested Capital over 5 years is $931.6 million, with a median of $935.0 million recorded in 2021.
  • Peak YoY movement for Invested Capital: fell 27.6% in 2022, then grew 23.96% in 2023.
  • A 5-year view of Invested Capital shows it stood at $925.4 million in 2021, then dropped by 4.97% to $879.4 million in 2022, then grew by 7.83% to $948.3 million in 2023, then increased by 1.52% to $962.7 million in 2024, then increased by 11.45% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Invested Capital are $1.1 billion (Q4 2025), $1.1 billion (Q3 2025), and $1.0 billion (Q2 2025).